Page last updated: 2024-10-27

gentamicin and Deafness-Retinitis Pigmentosa Syndrome

gentamicin has been researched along with Deafness-Retinitis Pigmentosa Syndrome in 2 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nudelman, I1
Glikin, D1
Smolkin, B1
Hainrichson, M1
Belakhov, V1
Baasov, T1
Goldmann, T1
Overlack, N1
Wolfrum, U1
Nagel-Wolfrum, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
European Research Projects on Rare Diseases Driven by Young Investigators[NCT01954953]100 participants (Anticipated)Observational2013-09-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for gentamicin and Deafness-Retinitis Pigmentosa Syndrome

ArticleYear
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
    Bioorganic & medicinal chemistry, 2010, Jun-01, Volume: 18, Issue:11

    Topics: Aminoglycosides; Animals; Codon, Nonsense; Cystic Fibrosis; Drug Design; Genetic Diseases, Inborn; G

2010
PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.
    Human gene therapy, 2011, Volume: 22, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Cycle Proteins; Cells, Cultured; Codon, Nonsense

2011